In several species the epidermal growth factor (EGF) is known to be a potent mitogen which ensures the integrity of the gut mucosa. In the pig its role in the gut was not investigated. Antisera against recombinant porcine EGF were raised in rabbits. The antiserum was used to screen EGFimmunoreactivity in histological sections of the duodenum and jejunum of healthy piglets and piglets with diarrhoea. The specificity of the staining reaction was ensured. Immunoreactivity was found in all goblet cells and their mucus but not in other cells of the gastrointestinal tract. The number of goblet cells in the duodenum of the sick animals was nearly twofold compared to healthy piglets. In the jejunum, the number of goblet cells was less strikingly increased in the piglets with diarrhoea (20%), but the mucus granule size was 2-fold. These data support the assumption that EGF from the goblet cells serves as a surveillance factor for gut mucosa integrity in the pig.
INTRODUCTION
The epidermal growth factor (EGF) is an acid protein with a molecular weight of 6.400 Da. It is a potent mitogen which participates in the development and 3 Corresponding author maintenance of the functional integrity in many tissues (Vaughan et al., 1991; Playford and Wright, 1996) . In the human species and in laboratory animals EGF could also be demonstrated in the mucous fluid of the gastrointestinal tract (Tunio and Hobsley, 1995) where the main part of EGF is derived from the mucus formation by the goblet cells (Takeyama et al., 1999) . In rodents also the salivary glands contribute to the intestinal lumen content (Playford and Wright, 1996) . The presence of EGF in the mucus of the intestinal tract is regarded to be an essential mechanism for intestinal ulcer healing (e.g., Wright et al., 1990; Tunio and Hobsley; 1995; Elliott etal., 2000) .
For postnatal morbidity and mortality in piglets diarrhoea is one of the major causes so that an understanding of factors regulating normal gut maintenance or counteracting dysfunction is essential (Odle et al., 1996) . Therefore it was our aim to rise a pig specific EGF antiserum, which is applicable for immunohistochemical studies and to screen whether EGF plays a role in the gut of healthy piglets and piglets with diarrhoea.
MATERIAL AND METHODS

Source of tissue samples
Four piglets (German Landrace x Pietrain) were included in the study. They were weaned at the age of 4 weeks and were thereafter fed with a conventional piglet-prestarter. They were killed by T61 (Hoechst-Roussel, OberschleiBheim, Germany) for tissue collection at an average age of 5 weeks. Two of the piglets suffered from severe diarrhoea and had been sent to the Chemical and Veterinary Institute (CVUA, Stuttgart) for examination. The piglets showed diarrhoea, retardation of growth, and a high mortality occured in the herd. A reduced mucosa and oedema in the mesentery were observed. In one piglet E. coli were identified, in the other piglet additionally (3-hemolizing E. coli and E. coli with mucous envelopes. The other two piglets were healthy and were obtained from the specific pathogen free (SPF) University population without clinical signs of diarrhoea.
Tissue samples were taken both from the duodenum and jejunum. Fixation was performed with methanol acetic acid. After dehydration in graded ethanol the specimen were embedded in paraffme.
Laboratory methods
Recombinant porcine EGF-protein was a gift from Dr. Takagi (Higeta Shoyn Co., Japan). The antigen was prepared by coupling pEGF to bovine serum albumin. The antiserum was raised in rabbits using a standard immunization protocol.
The radioimmunological characterization of the antisera was based on routine RIA-systems (Claus et al, 1992; Munz, 1998) . The serum was diluted 1:22.000. The species-specificity was determined by comparing the calibration curves obtained with porcine, human (Calbiochem, La Jolla, USA) and murine (PromegaBoehringer, Ingelheim Products, Heidelberg, Germany) EGF. Additionally the cross reactivities were determined for the transforming growth factor a (TGFa), the insulin-like growth factor-1 (IGF-1) and insulin. For immunohistochemical use, the IgG-fraction out of 1 ml portions of the EGF-antiserum was precipitated by sodium-sulphate. After centrifugation and washing with 18% sodium-sulphate solution, the pellet was redissolved in assay buffer.
Before staining for pEGF, the tissue samples were deparaffmized and rehydrated conventionally and were washed in citrate buffer (21.0 g citric acid monohydrate in 1:1 water, pH 6.0). They were then immersed in fresh citrate buffer and heated 5 times for 5 min in a microwave oven. The sections were cooled for 30 min at 4°C. To block endogenous peroxidase, the specimen were incubated in 3% H 2 0 2 methanol for 15 min and were washed in aqua dest and TBS (Tris-buffer solution, pH 7.5). To block unspecific binding, the sections were incubated with normal sheep serum. Thereafter the EGF-IgG-solution (1:1000) in TBS was applied and incubated for 1 h at 37°C. The sections were washed with TBS and covered with a biotinylated second antibody (sheep anti-rabbit IgG, Biozol, Eching, Germany) in a dilution of 1:400 in TBS for 30 min at room temperature. After washing in TBS, the tissues were treated with the streptavidin-biotin-horseradish-peroxidase complex (AB complex: Daco, Deisenhofen, Germany). Development was performed with diaminobenzidine (DAB; Sigma, Deisenhofen, Germany). After the final washing step, the specimen were counterstained in haemalaun. Inhibition studies were performed with irrelevant control peptides (IGF-I or insulin peptide) and pEGF peptide. The negative control was the performance of the staining procedure without the addition of the primary antibody.
From each animal 100 areas (counting fields) were randomly chosen both for the duodenum and jejunum. The cells were counted using a grid under a standardized magnification (x 400). All goblet cells were positively stained and their percentage in the epithelium in relation to the total number of epithelial cells was calculated. Because immunoreactivity was also found in mucus vesicles of the goblet cells, the diameter of these vesicles was measured using a grid and the area was calculated under the standardized magnification.
RESULTS
No cross reactivities were found for human and murine EGF, as well as for TGFa, IGF-1, and insulin. Neither preincubation with IGF-1 nor insulin did inhi-bit the immunohistochemical staining reaction, whereas preincubation of the antibodies with a surplus of pEGF peptide inhibited staining. The negative control did not lead to any staining.
Both in the duodenum and jejunum the immunoreactivity was limited to the goblet cells and their mucus (Figure 1 ). Neither enterocytes in the mucosa nor plasma cells and fibroblasts revealed immunostaining. A moderate staining of the mucus granules indicated their EGF-content (Figure 1) . The quantitative evaluation was separately performed for the duodenum and jejunum (Table 1 ). In the duodenum the total number of goblet cells and thus the percentage of positive cells was higher compared with the jejunum both for the healthy and the ill piglets. Nearly twofold numbers of goblet cells could be demonstrated in the ill animals compared to the healthy piglets in the duodenum. This difference probably is due to the health status because the two piglets in each group revealed similar values (healthy: 13.82% and 13.65% EGF positive cells, respectively; diarrhoea: 23.08 and 23.49%). In the jejunum neither the size of the goblet cells nor the number of total enterocytes per visual field were influenced by the health status, but the activity in the mucus area of the goblet cells was increased (healthy: 1.22 and 0.98 jim 2 ; diarrhoea: 0.55 |im 2 in both piglets). Whereas the number of goblet cells in the jejunum of the ill piglets was only moderatly higher than in the healthy animals, the activity was nearly 2-fold in the ill animals.
DISCUSSION
Earlier attempts to demonstrate enterocyte EGF production in the pig failed (Jaeger and Lamar, 1992) due to the low cross reactivity of the antibodies directed towards recombinant human EGF. Therefore, the demonstration of EGF in the pig goblet cells and their dependency on the health status are the first data obtained with an antiserum directed against porcine EGF. Even if only 2 piglets could be included in each health group, the data in the healthy piglets suggest that EGFproduction occurs in all goblet cells. These cells are more frequent in the duodenum (13.73%) of enterocytes) compared to the jejunum (10.7%). Staining was also present in the mucus granules in the goblet cells, so that the mucus layer over the intestinal epithelium is likely to form a reservoir of EGF. In the piglets with diarrhoea the frequency of goblet cells in the duodenum was nearly twofold compared with the healthy animals in the duodenum and the area of the mucus granules was increased by about 25% so that the total amount of EGF-containing mucus was remarkably increased. The volume of mucus seems to be stimulated by EGF itself, because perfusion of the lumen with EGF alone stimulated mucus secretion from goblet cells in rats (Ishikawa et al., 1994) .
The increase of both the number of goblet cells and their functional status due to diarrhoea, fits to the suggested role of EGF as a surveillance peptide which is readily available to stimulate repair at sites of injury (e.g., Petschow et al., 1993; . The fact that EGF is acitve only when the integrity of the gut is incomplete such as in newborn animals and at sites of injury, probably is explained by the location of the EGF-receptor in the basolateral membranes of the human and porcine gut (Kelly et al., 1992; . A mitogenic effect of EGF on intestinal stem cells in the basolateral compartment is known and may involve both the formation of enterocytes and goblet cells (Kong et al., 1998) .
